Avera Health, Sema4 Launch Joint Five-Year Precision Oncology Study

Inside Precision Medicine featured Avera Health and Sema4’s joint study, which is expected to enable precision oncology care for thousands of patients. This initiative builds on Avera and Sema4’s previously announced collaboration to improve cancer care, enabling Avera’s physicians and patients to benefit from data-driven insights that inform targeted treatments.